ALVR Insider Trading
Insider Ownership Percentage: 32.07%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $76,657.53
AlloVir Share Price & Price History
Current Price: $6.70
Price Change: ▲ Price Increase of +0.18 (2.76%)
As of 04/25/2025 01:00 AM ET
AlloVir Insider Trading History
AlloVir Institutional Trading History
Data available starting January 2016
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.
Read More on AlloVir
Volume
13,922 shs
Average Volume
16,075 shs
Market Capitalization
$33.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.63
Who are the company insiders with the largest holdings of AlloVir?